Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stemirac Safety and Efficacy in Acute Traumatic Spinal Cord Injury with Out-of-Spec Product
jRCT2013210056Recruiting
- Sponsor
- Nipro Corporation
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of milciclib in acute spinal cord injury (SCI), sponsored by Nipro Corporation. Started Dec 2021; status: recruiting.
02
Drugs
milciclib
03
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT2013210056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2013210056.